Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Blood Cancer Journal|June 25, 2016
A data-driven network model of primary myelofibrosis: transcriptional and post-transcriptional alterations in CD34+ cellsE Calura, S Pizzini, A Bisognin, et al.
Leukemia|May 29, 2010
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosisA Tefferi, T L Lasho, O Abdel-Wahab, et al.
Leukemia|October 24, 2013
Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasmsE Tenedini, I Bernardis, V Artusi, et al.
Leukemia|June 27, 2015
Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locusA Chase, W Leung, W Tapper, et al.
Leukemia|June 1, 2017
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosisF Passamonti, T Giorgino, B Mora, et al.
Leukemia|July 27, 2017
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patientsS Ruberti, E Bianchi, P Guglielmelli, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Leukemia|April 27, 2013
Mutations and prognosis in primary myelofibrosisA M Vannucchi, T L Lasho, P Guglielmelli, et al.
Blood Cancer Journal|November 5, 2016
Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patientsV De Stefano, A M Vannucchi, M Ruggeri, et al.
Leukemia|July 18, 2013
Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) studyJ V Jovanovic, A Ivey, A M Vannucchi, et al.
Pageof 3